Molecular mechanisms of cadmium-induced fibroblast growth factor 23 upregulation in osteoblast-like cells

Toxicological Sciences

Volumn 139, Issue 2, 2014, Pages 301-316

  Kido, Shinsuke ^a   Fujihara, Marina ^a   Nomura, Kengo ^a   Sasaki, Shohei ^a   Mukai, Rie ^a   Ohnishi, Ritsuko ^a   Kaneko, Ichiro ^a   Segawa, Hiroko ^a   Tatsumi, Sawako ^a   Izumi, Hiroto ^b   Kohno, Kimitoshi ^b   Miyamoto, Ken Ichi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Bone; Cadmium; Fibroblast growth factor 23; Hypophosphatemia; Processing

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CADMIUM; FIBROBLAST GROWTH FACTOR 23; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE; SMALL INTERFERING RNA; CADMIUM CHLORIDE; FIBROBLAST GROWTH FACTOR; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADMIUM POISONING; CELL CULTURE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; OSTEOBLAST; OSTEOCYTE; OSTEOSARCOMA CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; TRABECULAR BONE; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; CULTURE TECHNIQUE; DRUG EFFECTS; FEMUR; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHOSPHORYLATION; TOXICITY; TUMOR CELL LINE;

ANIMALS; CADMIUM CHLORIDE; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; FEMALE; FEMUR; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; MICE, INBRED C57BL; MICE, INBRED ICR; N-ACETYLGALACTOSAMINYLTRANSFERASES; OSTEOBLASTS; OSTEOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, ARYL HYDROCARBON; UP-REGULATION;

EID: 84899983795     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfu043     Document Type: Article

References (46)

1. ADHR Consortium. (2000). Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348.
2. Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw,M. L., Pettersson, S., Hanberg, A., and Poellinger, L. (2002).Aconstitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 99, 9990-9995.
3. Aoshima, K., and Kasuya, M. (1991). Preliminary study on serum levels of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D in cadmium-induced renal tubular dysfunction. Toxicol. Lett. 57, 91-99.
4. Aoshima, K., Katoh, T., Teranishi, H., Horiguchi, H., and Kasuya, M. (1993). Abnormalities of calcium, phosphorous and vitaminDmetabolismwith proximal renal tubular dysfunction in subjects environmentally exposed to cadmium Nihon Eiseigaku Zasshi 47, 1009-1020.
5. Aranami, F., Segawa, H., Furutani, J., Kuwahara, S., Tominaga, R., Hanabusa, E., Tatsumi, S., Kido, S., Ito, M., and Miyamoto,K. (2010). Fibroblast growth factor 23 mediates the phosphaturic actions of cadmium. J. Med. Invest. 57, 95-108.
6. Bhattacharyya, N., Chong, W. H., Gafni, R. I., and Collins, M. T. (2012a). Fibroblast growth factor 23: State of the field and future directions. Trends Endocrinol. Metab. 23, 610-618.
7. Bhattacharyya, M. H., Whelton, B. D., Peterson, D. P., Carnes, B. A., Moretti, E. S., Toomey, J. M., and Williams, L. L. (1988a). Skeletal changes in multiparous mice fed a nutrient-sufficient diet containing cadmium. Toxicology 50, 193-204.
8. Bhattacharyya,M. H., Whelton, B. D., Stern, P. H., and Peterson, D. P. (1988b). Cadmium accelerates bone loss in ovariectomized mice and fetal rat limb bones in culture. Proc. Natl. Acad. Sci. U.S.A. 85, 8761-8765.
9. Bhattacharyya, N., Wiench,M., Dumitrescu, C., Connolly, B.M., Bugge, T. H., Patel, H. V., Gafni, R. I., Cherman, N., Cho, M., Hager, G. L., et al. (2012b). Mechanism of FGF23 processing in fibrous dysplasia. J. Bone Miner. Res. 27, 1132-1141.
10. Brzoska, M. M., and Moniuszko-Jakoniuk, J. (2005). Bone metabolism of male rats chronically exposed to cadmium. Toxicol. Appl. Pharmacol. 207, 195- 211.
11. Carlson, D. B., and Perdew, G. H. (2002). A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J. Biochem. Mol. Toxicol. 16, 317-325.
12. Chefetz, I., Kohno, K., Izumi, H., Uitto, J., Richard, G., and Sprecher, E. (2009). GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim. Biophys. Acta 1792, 61-67.
13. Chefetz, I., and Sprecher, E. (2009). Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. Biochim. Biophys. Acta 1792, 847-852.
14. Chuang, S. M., Wang, I. C., and Yang, J. L. (2000). Roles of JNK, p38 and ERKmitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 21, 1423-1432.
15. Elbekai, R. H., and El-Kadi, A. O. (2004). Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium. Toxicology 202, 249-269.
16. Elbekai, R. H., and El-Kadi, A. O. (2007). Transcriptional activation and posttranscriptionalmodification of Cyp1a1 by arsenite, cadmium, and chromium. Toxicol. Lett. 172, 106-119.
17. Farrow, E. G., Davis, S. I., Summers, L. J., and White, K. E. (2009). Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J. Am. Soc. Nephrol. 20, 955-960.
18. Farrow, E. G., Yu, X., Summers, L. J., Davis, S. I., Fleet, J. C., Allen, M. R., Robling, A. G., Stayrook, K. R., Jideonwo, V., Magers, M. J., et al. (2011). Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc. Natl. Acad. Sci. U.S.A. 108, E1146-E1155.
19. Frishberg, Y., Ito, N., Rinat, C., Yamazaki, Y., Feinstein, S., Urakawa, I., Navon-Elkan, P., Becker-Cohen, R., Yamashita, T., Araya, K., et al. (2007). Hyperostosis-hyperphosphatemia syndrome: A congenital disorder of Oglycosylation associated with augmented processing of fibroblast growth factor 23. J. Bone Miner. Res. 22, 235-342.
20. Fukumoto, S. (2005). Post-translationalmodification of fibroblast growth factor 23. Ther. Apher. Dial. 9, 319-22.
21. Galan, A., Garcia-Bermejo, M. L., Troyano, A., Vilaboa, N. E., de Blas, E., Kazanietz, M. G., and Aller, P. (2000). Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J. Biol. Chem. 275, 11418-11424.
22. Garrison, P. M., Tullis, K., Aarts, J. M., Brouwer, A., Giesy, J. P., and Denison, M. S. (1996). Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam. Appl. Toxicol. 30, 194-203.
23. Gu, G., Nars, M., Hentunen, T. A., Metsikko, K., and Vaananen, H. K. (2006). Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res. 323, 263-271.
24. Hung, J. J., Cheng, T. J., Lai, Y. K., and Chang, M. D. (1998). Differential activation of p38 mitogen-activated protein kinase and extracellular signalregulated protein kinases confers cadmium-induced HSP70 expression in 9L rat brain tumor cells. J. Biol. Chem. 273, 31924-31931.
25. Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004). Cell density regulates intracellular localization of aryl hydrocarbon receptor. J. Biol. Chem. 279, 19209- 19216.
26. Imel, E. A., Peacock, M., Gray, A. K., Padgett, L. R., Hui, S. L., and Econs, M. J. (2011). Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J. Clin. Endocrinol. Metab. 96, 3541-3549.
27. Kato, K., Jeanneau, C., Tarp, M. A., Benet-Pages, A., Lorenz-Depiereux, B., Bennett, E. P., Mandel, U., Strom, T. M., and Clausen, H. (2006). Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370- 18377.
28. Kido, S., Kuriwaka-Kido, R., Imamura, T., Ito, Y., Inoue, D., and Matsumoto, T. (2009). Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation. Bone 45, 1125-1132.
29. Kido, S., Kuriwaka-Kido, R., Umino-Miyatani, Y., Endo, I., Inoue, D., Taniguchi, H., Inoue, Y., Imamura, T., and Matsumoto, T. (2010). Mechanical stress activates Smad pathway through PKCdelta to enhance interleukin- 11 gene transcription in osteoblasts. PLoS One 5. e13090.
30. Kjellstroem, T.,1986. Itai-itai disease. In: Cadmium and health: A toxicological and epidemiological appraisal (L. Friberg, C. G. Elinder, T. Kjellstroem and G. F. Nordberg Eds.), Vol. 11, pp. 257-290, Effects of Response. CRC Press, Boca Raton, Florida.
31. Lee, J. E., and Safe, S. (2000). 3',4'-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol. Sci.58, 235-242.
32. Liu, S., Guo, R., Simpson, L. G., Xiao, Z. S., Burnham, C. E., and Quarles, L. D. (2003). Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J. Biol. Chem. 278, 37419-37426.
33. Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., and Quarles, L. D. (2006). Pathogenic role of Fgf23 in Hyp mice. Am. J. Physiol. Endocrinol. Metab. 291, E38-E49.
34. Lu, Y., and Feng, J. Q. (2011). FGF23 in skeletal modeling and remodeling. Curr. Osteoporos. Rep. 9, 103-108.
35. Nomoto, M., Izumi, H., Ise, T., Kato, K., Takano, H., Nagatani, G., Shibao, K., Ohta, R., Imamura, T., Kuwano, M., et al. (1999). Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: Polypeptide Nacetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res. 59, 6214-6222.
36. Sacco-Gibson, N., Chaudhry, S., Brock, A., Sickles, A. B., Patel, B., Hegstad, R., Johnston, S., Peterson, D., and Bhattacharyya, M. (1992). Cadmium effects on bone metabolism: Accelerated resorption in ovariectomized, aged beagles. Toxicol. Appl. Pharmacol. 113, 274-283.
37. Shimada, T.,Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., and Yamashita, T. (2001). Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. U.S.A. 98, 6500-6505.
38. Sogawa, K., Numayama-Tsuruta, K., Takahashi, T., Matsushita, N., Miura, C., Nikawa, J., Gotoh, O., Kikuchi, Y., and Fujii-Kuriyama, Y. (2004). A novel induction mechanism of the rat CYP1A2 gene mediated by Ah receptor-Arnt heterodimer. Biochem. Biophys. Res. Commun. 318, 746-755.
39. Topaz, O., Shurman, D. L., Bergman, R., Indelman,M., Ratajczak, P., Mizrachi, M., Khamaysi, Z., Behar, D., Petronius, D., Friedman, V., et al. (2004). Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat. Genet. 36, 579-581.
40. Uchida, M., Teranishi, H., Aoshima, K., Katoh, T., Kasuya, M., and Inadera, H. (2007). Elevated urinary levels of vitamin D-binding protein in the inhabitants of a cadmium polluted area, Jinzu River basin, Japan. Tohoku J. Exp. Med. 211, 269-274.
41. Uriu, K., Morimoto, I., Kai, K., Okazaki, Y., Okada, Y., Qie, Y. L., Okimoto, N., Kaizu, K., Nakamura, T., and Eto, S. (2000). Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure. Toxicol. Appl. Pharmacol. 164, 264-272.
42. Wang, Z., and Templeton, D. M. (1998). Induction of c-fos proto-oncogene in mesangial cells by cadmium. J. Biol. Chem. 273, 73-79.
43. White, K. (2000). Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348.
44. Wilson, A. K., and Bhattacharyya, M. H. (1997). Effects of cadmium on bone: An in vivo model for the early response. Toxicol. Appl. Pharmacol. 145, 68- 73.
45. Wilson, A. K., Cerny, E. A., Smith, B. D., Wagh, A., and Bhattacharyya, M. H. (1996). Effects of cadmium on osteoclast formation and activity in vitro. Toxicol. Appl. Pharmacol. 140.
46. Yamashita, H., and Kitagawa, M. (1996). Histomorphometric study of ribs with looser zones in Itai-itai disease. Calcif. Tissue Int. 58, 170-176.